z-logo
Premium
Parthenogenetic Activation of Pig Oocytes Using Pulsatile Treatment with a Nitric Oxide Donor
Author(s) -
Petr J,
Chmelíková E,
Krejčová T,
Řehák D,
Novotná B,
Jílek F
Publication year - 2010
Publication title -
reproduction in domestic animals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 66
eISSN - 1439-0531
pISSN - 0936-6768
DOI - 10.1111/j.1439-0531.2008.01275.x
Subject(s) - nitric oxide , andrology , snap , blastocyst , oocyte , chemistry , parthenogenesis , pulsatile flow , embryo , medicine , endocrinology , embryogenesis , biology , microbiology and biotechnology , computer graphics (images) , computer science
Contents The nitric oxide donor (+)–S‐nitroso‐N‐acetylpenicillamine (SNAP) is capable of inducing parthenogenetic activation in pig oocytes matured in vitro . However, quite a long exposure to the nitric oxide donor, exceeding 10 h, is necessary for successful oocyte activation. Repeated short‐term treatment with 2 m m SNAP significantly increased the activation rates despite the fact that the overall exposure time to the nitric oxide donor did not exceed 4 h. With regard to the activation rate, 12 repeated treatments lasting 10 min each were found to be the most efficient regimen (63.3%). The continuous exposure to the nitric oxide donor for the same overall time induced parthenogenetic activation in 12.5% oocytes (2‐h continuous treatment with 2 m m SNAP). The development of parthenogenetic embryos increased after repeated short‐term treatment with SNAP. After continuous treatment with 2 m m SNAP for 10 h, only 6.7% of the oocytes cleaved, and none developed beyond the 4‐cell stage. Thirty‐minute treatment repeated four times with 2 m m SNAP induced cleavage in 37.5% of the oocytes, 18.3% developed to the morula stage, and 6.7% reached the blastocyst stage. Based on the results, it is concluded that pulsatile treatment can significantly improve parthenogenetic activation rate when compared with the continuous treatment using nitric oxide donors.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here